on VALBIOTIS (EPA:ALVAL)
Valbiotis Wins 2025 Top Santé Award for Valbiotis Plus® Serenity
Valbiotis, a French laboratory, has been awarded the 2025 Top Santé Award for its product Valbiotis Plus® Serenity. This accolade, given during the 6th Top Santé Awards, recognizes innovative health solutions across 19 categories. The selection is made by a panel of journalists and health experts, focusing on criteria like efficacy and innovation.
The award highlights Valbiotis’ commitment to scientific excellence, from research to commercialization. Its product, Valbiotis Plus® Serenity, targets emotional balance with an innovative and ethical approach, reinforcing the brand’s growth strategy amidst increasing mental well-being concerns in France.
This recognition reflects a rising demand for effective, natural health solutions, positioning Valbiotis for growth potential in related health segments.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all VALBIOTIS news